Zirconium-89 NY 005 - Norroy Bioscience
Alternative Names: 89Zr NY-005; Zirconium-89 NY-005Latest Information Update: 05 Nov 2024
Price :
$50 *
At a glance
- Originator Norroy Bioscience
- Class Imaging agents; Radioisotopes; Radiopharmaceutical diagnostics
- Mechanism of Action Positron-emission tomography enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Clinical Phase Unknown Gastric cancer; Pancreatic cancer
Most Recent Events
- 31 Jul 2024 Clinical trials in Gastric cancer (Diagnosis) in China (unspecified route) prior to July 2024 (Norroy Bioscience pipeline; July 2024)
- 31 Jul 2024 Clinical trials in Pancreatic cancer (Diagnosis) in China (unspecified route) prior to July 2024 (Norroy Bioscience pipeline; July 2024)